Durect (DRRX) announced the sale of its Alzet line of osmotic pumps to Lafayette Instrument, or LIC, a portfolio company of Branford Castle Partners II, a North-American focused private equity firm. Under the terms of the agreement, LIC paid Durect $17.5M in exchange for certain assets and liabilities associated with the Alzet product line. Simultaneous with this transaction, Durect has paid off all remaining obligations under the term loan agreement with Oxford Finance. Aquilo Partners acted as financial advisor and Wilson, Sonsini, Goodrich & Rosati acted as legal advisor to Durect.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DRRX:
- DURECT Corporation’s Q3 2024 Financial Highlights
- Durect reports Q3 EPS (14c), consensus (17c)
- DURECT Corporation (DRRX) Q3 Earnings Cheat Sheet
- Durect Corp Annual Meeting Decisions and Shareholder Votes
- Durect agreement on larsucosterol trial ‘a major positive,’ says Northland
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
